Randomized trials stopped early for benefit: A systematic review

JAMA

Volumn 294, Issue 17, 2005, Pages 2203-2209

  Montori, Victor M ^a,b   Devereaux, P J ^a   Adhikari, Neill K J ^a,c   Burns, Karen E A ^a,c   Eggert, Christoph H ^b   Briel, Matthias ^d   Lacchetti, Christina ^a   Leung, Teresa W ^a   Darling, Elizabeth ^a   Bryant, Dianne M ^a   Bucher, Heiner C ^d   Schünemann, Holger J ^a,e,f   Meade, Maureen O ^a   Cook, Deborah J ^a   Erwin, Patricia J ^b   Sood, Amit ^b   Sood, Richa ^b   Lo, Benjamin ^a   Thompson, Carly A ^a   Zhou, Qi ^a   Mills, Edward ^a   Guyatt, Gordon H ^a   more..

^a MCMASTER UNIVERSITY   (Canada)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

^e UNIVERSITY AT BUFFALO   (United States)

^f REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DATA BASE; EMBASE; EPIDEMIOLOGICAL DATA; FINANCIAL MANAGEMENT; FOLLOW UP; MEDLINE; MONITORING; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SAFETY; SAMPLING; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

EID: 27644487803     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.294.17.2203     Document Type: Review

References (20)

1. Poldermans D, Boersma E, Bax JJ, et al; Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. N Engl J Med. 1999;341:1789-1794.
2. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345:1359-1367.
3. Pocock S, White I. Trials stopped early: too good to be true? Lancet. 1999;353:943-944.
4. Guyatt G, Rennie D. Users' Guides to the Medical Literature: A Manual of Evidence-Based Clinical Practice. Chicago, Ill: AMA Press; 2002.
5. Moher D, Schulz KF, Altman D. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA. 2001;285:1987-1991.
6. Cook R, Farewell V. Conditional inference for subject-specific and marginal agreement: two families of agreement measures. Can J Stat. 1995;23:333-344.
7. Montori VM, Permanyer-Miralda G, Ferreira-Gonzalez I, et al. Validity of composite end points in clinical trials. BMJ. 2005;330:594-596.
8. Cannistra SA. The ethics of early stopping rules: who is protecting whom? J Clin Oncol. 2004;22:1542-1545.
9. Juurlink DN, Mamdani MM, Lee DS, et al. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med. 2004;351:543-551.
10. Pocock SJ, Hughes MD. Practical problems in interim analyses, with particular regard to estimation. Control Clin Trials. 1989;10(4 suppl):209S-221S.
11. Guyatt G, Montori V, Devereaux PJ, Schunemann H, Bhandari M. Patients at the center: in our practice, and in our use of language. ACP J Club. 2004;140:A11-A12.
12. Devereaux PJ, Yusuf S, Yang H, Choi PT, Guyatt GH. Are the recommendations to use perioperative beta-blocker therapy in patients undergoing noncardiac surgery based on reliable evidence? CMAJ. 2004;171:245-247.
13. Yang H, Raymer K, Butler R, Parlow J, Roberts R, Tech M. Metoprolol after vascular surgery (MAVS). Can J Anaesth. 2004;51:A7.
14. Wheatley K, Clayton D. Be skeptical about unexpected large apparent treatment effects: the case of an MRC AML12 randomization. Control Clin Trials. 2003;24:66-70.
15. Slutsky AS, Lavery JV. Data safety and monitoring boards. N Engl J Med. 2004;350:1143-1147.
16. Lan K, DeMets D. Discrete sequential boundaries for clinical trials. Biometrika. 1983;70:659-663.
17. Prandoni P, Bruchi O, Sabbion P, et al. Prolonged thromboprophylaxis with oral anticoagulants after total hip arthroplasty: a prospective controlled randomized study. Arch Intern Med. 2002;162:1966-1971.
18. Lan KK, Wittes J. The B-value: a tool for monitoring data. Biometrics. 1988;44:579-585.
19. Palda VA, Detsky AS. Perioperative assessment and management of risk from coronary artery disease. Ann Intern Med. 1997;127:313-328.
20. Eagle KA, Berger PB, Calkins H, et al; American College of Cardiology/American Heart Association. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol. 2002;39:542-553.